James Harnett, PharmD, MS
Articles
October 23rd 2013
Inefficiencies in Osteoarthritis and Chronic Low Back Pain Management
Margaret K. Pasquale, PhD Robert Dufour, PhD Ashish V. Joshi, PhD Andrew T. Reiners, MD David Schaaf, MD Jack Mardekian, PhD George A. Andrews, MD, MBA, CPE Nick C. Patel, PharmD, PhD, BCPP James Harnett, PharmD, MS
This study identified inefficiencies in drug and medical service utilization related to pain management among Medicare members with osteoarthritis and chronic low back pain.
September 22nd 2010
Utilization Management for Smoking Cessation Pharmacotherapy: Varenicline Rejected Claims Analysis
Feng Zeng, PhD Chieh-I Chen, MPH Vera Mastey, MS, BPharm Kelly H. Zou, PhD James Harnett, PharmD, MS Bimal V. Patel, PharmD, MS
About half of the patients in this study did not fill any smoking cessation medication following a rejected claim for varenicline.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: August 28th 2024 | Updated: September 8th 2024
Illuminating the Future: Dr Kristen Whitney on What's Next for Dermoscopy
Published: August 4th 2024 | Updated: September 8th 2024
Who Should Have Lp(a) Levels Tested? Experts Take Sides
Published: September 3rd 2024 | Updated: September 8th 2024
ASCERTAIN Data: Oral Decitabine-Cedazuridine Outcomes in MDS
Published: September 3rd 2024 | Updated: September 8th 2024
Luspatercept in Lower Risk MDS: Insights on the COMMANDS Trial
Published: August 28th 2024 | Updated: September 8th 2024
TYK2 Inhibitor Zasocitinib Shows High Efficacy, Safety in Moderate to Severe Psoriasis
